Adial Pharmaceuticals, Inc. (ADIL) NASDAQ

0.36

-0.0059(-1.62%)

Updated at October 21 04:00PM

Currency In USD

Adial Pharmaceuticals, Inc.

Address

1180 Seminole Trail

Charlottesville, VA 22901

United States of America

Phone

434 422 9800

Sector

Healthcare

Industry

Biotechnology

Employees

5

First IPO Date

July 27, 2018

Key Executives

NameTitlePayYear Born
Mr. Cary John Claiborne MBAChief Executive Officer, President & Director561,3311961
Mr. Tony GoodmanChief Operating Officer & Director328,5001964
Dr. Brigette Robertson M.D.Acting Chief Medical Officer01964
Mr. John R. Martin J.D.Chief Legal Officer0N/A
Mr. Vinay Shah A.C.A., M.B.A.Chief Financial Officer & Treasurer01963
Andrew TaubmanVice President of Corporate Development0N/A
Mr. Abel Svitavsky CPAController0N/A

Description

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.